Qiagen N.V.

QGEN

Cena:

$ 35.54

+0.37 (1.05%)

Valuace

Růst

Zdraví

Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři

Souhrn

Finanční data

Pro investory

Předpovědi

Zprávy

Dividendy

Zisky

Návštěvnost webu

Akcionáři

Zprávy

Zahraniční články

Tiskové zprávy

Dokumenty ke stáhnutí

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN

17:35 26-05-2026

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.

20:00 21-05-2026

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investi...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN

15:25 21-05-2026

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

QIAGEN Stock Up on the Launch of AI-Powered Workflow Agent Platform

13:55 21-05-2026

QGEN's new QIA Agent platform uses conversational AI to streamline experiment planning and ordering ...

QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows

16:05 20-05-2026

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Fr...

Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky

9:00 20-05-2026

Qiagen shares dropped more than 10% after the company slashed FY 2026 sales-growth guidance from "at...

QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.

19:00 19-05-2026

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN

17:11 19-05-2026

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest...

QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on Behalf of Qiagen Stockholders and Encourages Investors to Contact the Firm

10:47 15-05-2026

Bragar Eagel and Squire, P. C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L...

QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V.

10:47 15-05-2026

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffere...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN

22:20 14-05-2026

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ...

QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

19:00 14-05-2026

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of...

Levi & Korsinsky Announces Investigation of Securities Claims Against Qiagen N.V. (QGEN)

9:00 14-05-2026

Qiagen's CEO and CFO signed SEC filings and personally delivered the guidance that was slashed withi...

QGEN Investor Alert: Levi & Korsinsky Investigates Qiagen (QGEN) for Potential Securities Fraud

9:00 13-05-2026

Qiagen's forward-looking non-GAAP guidance lacked required GAAP reconciliations under SEC Regulation...

Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

0:20 13-05-2026

Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript...

Deciphering Qiagen (QGEN) International Revenue Trends

10:16 11-05-2026

Examine Qiagen's (QGEN) international revenue patterns and their implications on Wall Street's forec...

Lost Money on Qiagen N.V. (QGEN)? Contact Levi & Korsinsky to Protect Your Rights

0:08 11-05-2026

New York, New York--(Newsfile Corp. - May 11, 2026) - Levi & Korsinsky notifies investors that it ha...

Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript

20:31 08-05-2026

Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent...

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations

9:00 07-05-2026

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Qiagen (NASDAQ: QGEN) investors lost approximately 10% of...

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

6:00 07-05-2026

VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Stan...

QIAGEN EXCEEDS Q4 2025 OUTLOOK DRIVEN BY GROWTH PILLARS

04-02-2026

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME STAN...

Více zde

QIAGEN SHOWCASES QIASPRINT CONNECT HIGH-THROUGHPUT AUTOMATION SYSTEM FOR LABS WORLDWIDE AT SLAS 2026

03-02-2026

GERMANTOWN, MD. & VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FR...

Více zde

QIAGEN APPOINTS MARK STEVENSON TO SUPERVISORY BOARD

26-01-2026

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; FRANKFURT PRIME STANDARD:...

Více zde

QIAGEN N.V. TO RELEASE RESULTS FOR Q4 2025 AND HOLD WEBCAST

19-01-2026

VENLO, NETHERLANDS--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (FRANKFURT STOCK EXCHANGE: QIA) TODAY ...

Více zde

QIAGEN SETS 2026 PRIORITIES TO DRIVE GROWTH ACROSS FIVE PILLARS TOWARD ACHIEVING 2028 GOALS FOR SOLID PROFITABLE GROWTH

12-01-2026

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME STAN...

Více zde

QIAGEN ANNOUNCES DETAILS FOR COMPLETION OF SYNTHETIC SHARE REPURCHASE OF UP TO APPROXIMATELY $500 MILLION

18-12-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME STAN...

Více zde

QIAGEN UNVEILS QIASYMPHONY CONNECT AND SHOWCASES NEW PRECISION ONCOLOGY INNOVATIONS AT AMP 2025

10-11-2025

GERMANTOWN, MD. & VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FR...

Více zde

QIAGEN EXCEEDS Q3 2025 OUTLOOK, RAISES FY 2025 ADJ. EPS TARGET, ANNOUNCES PARSE ACQUISITION AND $500 MILLION SHARE REPURCHASE

04-11-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME STAN...

Více zde

QIAGEN TO ACQUIRE PARSE BIOSCIENCES, EXPANDING ITS SAMPLE TECHNOLOGIES PORTFOLIO INTO HIGHLY SCALABLE SINGLE-CELL SOLUTIONS

04-11-2025

VENLO, NETHERLANDS & SEATTLE--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; FRANKFURT PRIME...

Více zde

QIAGEN MARKS 4,000TH QIACUBE CONNECT PLACEMENT, REAFFIRMING LEADERSHIP IN AUTOMATED SAMPLE PROCESSING

28-10-2025

VENLO, NETHERLANDS, & GERMANTOWN, MARYLAND--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; F...

Více zde

QIAGEN N.V. TO RELEASE RESULTS FOR Q3 2025 AND HOLD WEBCAST

13-10-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (FRANKFURT STOCK EXCHANGE: QIA) TODAY ...

Více zde

QIAGEN SECURES EUROPEAN CE-IVDR CERTIFICATION FOR FULL QIASTAT-DX PORTFOLIO

10-09-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; FRANKFURT PRIME STANDARD:...

Více zde

QIAGEN GAINS U.S. CLEARANCE OF HIGHER-THROUGHPUT QIASTAT-DX RISE, EXPANDING PATIENT ACCESS TO RAPID SYNDROMIC TESTING

02-09-2025

GERMANTOWN, MD. & VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FR...

Více zde

QIAGEN N.V. ANNOUNCES CONVERSION PRICE OF NEW NET SHARE SETTLED CONVERTIBLE BONDS

28-08-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION ...

Více zde

QIAGEN N.V. ANNOUNCES SUCCESSFUL PLACEMENT OF NEW NET SHARE SETTLED CONVERTIBLE BONDS

28-08-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION ...

Více zde

QIAGEN N.V. LAUNCHES NON-US OFFERING OF NET SHARE SETTLED CONVERTIBLE BONDS

28-08-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION ...

Více zde

QIAGEN EXCEEDS OUTLOOK FOR Q2 2025 WITH SOLID GROWTH AND IMPROVED PROFITABILITY

05-08-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME STAN...

Více zde

QIAGEN EXPANDS NGS PORTFOLIO WITH LAUNCH OF QIASEQ XHYB LONG READ PANELS

22-07-2025

VENLO, THE NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; FRANKFURT PRIME STAND...

Více zde

QIAGEN N.V. TO RELEASE RESULTS FOR Q2 2025 AND HOLD WEBCAST

08-07-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)--QIAGEN N.V. TO RELEASE RESULTS FOR Q2 2025 AND HOLD WEBCAST....

Více zde

QIAGEN ANNOUNCES ELECTION OF STEPHEN RUSCKOWSKI AS CHAIRMAN OF SUPERVISORY BOARD

26-06-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME STAN...

Více zde

QIAGEN AND GENCURIX ANNOUNCE QIACUITY DIGITAL PCR IVD ASSAY DEVELOPMENT PARTNERSHIP

18-06-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; FRANKFURT PRIME STANDARD:...

Více zde

QIAGEN AND INCYTE ANNOUNCE PRECISION MEDICINE COLLABORATION TO DEVELOP COMPANION DIAGNOSTICS FOR PATIENTS WITH MUTANT CALR-EXPRESSING MYELOPROLIFERATIVE NEOPLASMS (MPNS)

15-06-2025

VENLO, NETHERLANDS & WILMINGTON, DEL.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; F...

Více zde

TRACER BIOTECHNOLOGIES ANNOUNCES STRATEGIC PARTNERSHIP WITH QIAGEN TO ADVANCE BLOOD-BASED MRD TESTING FOR SOLID TUMORS

05-06-2025

NEW YORK--(BUSINESS WIRE)--TRACER BIOTECHNOLOGIES, A LEADER IN BLOOD-BASED MOLECULAR DIAGNOSTICS FOR...

Více zde

QIAGEN EXPANDS PORTFOLIO FOR MINIMAL RESIDUAL DISEASE (MRD) TESTING IN ONCOLOGY WITH NEW STRATEGIC PARTNERSHIPS

02-06-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; FRANKFURT PRIME STANDARD:...

Více zde

FORESIGHT DIAGNOSTICS AND QIAGEN ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE DEVELOPMENT OF COMPANION DIAGNOSTIC KITS FOR LYMPHOMA

02-06-2025

BOULDER, COLO. , JUN 2, 2025 /PRNEWSWIRE/ -- FORESIGHT DIAGNOSTICS, A LEADING DIAGNOSTICS COMPANY SP...

Více zde

QIAGEN EXPANDS DIGITAL PCR ONCOLOGY RESEARCH PORTFOLIO THROUGH PARTNERSHIP WITH ID SOLUTIONS

22-05-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; FRANKFURT PRIME STANDARD: QIA) TODAY ANNOUN...

Více zde

QIAGEN ANNOUNCES PLANS FOR TRANSITION IN LEADERSHIP OF SUPERVISORY BOARD

07-05-2025

VENLO, THE NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME ...

Více zde

QIAGEN TO PROPOSE INITIATION OF ANNUAL CASH DIVIDEND FOR SHAREHOLDER APPROVAL AT ANNUAL GENERAL MEETING

07-05-2025

VENLO, THE NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME ...

Více zde

QIAGEN EXPANDS ITS DIGITAL PCR PORTFOLIO WITH NEW LENTIVIRUS SOLUTIONS TO STRENGTHEN CELL AND GENE THERAPY QUALITY CONTROL

29-04-2025

VENLO, THE NETHERLANDS--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; FRANKFURT PRIME STANDARD: QIA) TODAY AN...

Více zde

QIAGEN ADVANCES CANCER GENOMIC PROFILING WITH NEW PRODUCTS AND PARTNERSHIP UPDATES AT AACR ANNUAL MEETING 2025

22-04-2025

VENLO, NETHERLANDS--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; FRANKFURT PRIME STAN...

Více zde

Dokumenty nejsou k dispozici